Abstract Background Upper urothelial cancer (UUC), i.e. transitional cell carcinomas of the renal pelvis and the ureter, occur at an increased frequency in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Defective mismatch repair (MMR) specifically characterizes HNPCC-associated tumors, but also occurs in subsets of some sporadic tumors, e.g. in gastrointestinal cancer and endometrial cancer. Methods We assessed the contribution of defective MMR to the development of UUC in a population-based series from the southern Swedish Cancer Registry, through microsatellite instability (MSI) analysis and immunohistochemical evaluation of expression of the MMR proteins MLH1, PMS2, MSH2, and MSH6. Results A MSI-high phenotype was ident...
Background: Immunohistochemical staining for mismatch repair proteins is efficient and widely used t...
Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. A...
Background: Patients with early-onset colorectal cancer (CRC) or those with multiple tumours associa...
Urothelial carcinoma of the renal pelvis and ureter may develop sporadically or as a manifestation o...
Urothelial carcinoma of the renal pelvis and ureter may develop sporadically or as a manifestation o...
Urothelial carcinoma of the renal pelvis and ureter may develop as a manifestation of the hereditary...
Inactivation of the DNA mismatch repair (MMR) system is a tumorigenic mechanism involved in 15-20% o...
To date, two forms of microsatellite instability (MSI) have been described in human cancer. MSI typi...
Introduction: Lynch syndrome-associated cancer develops due to germline pathogenic variants in one o...
BACKGROUND. Patients with the familial syndrome hereditary nonpolyposis colorectal carcinoma (HNPCC)...
Mismatch repair (MMR) deficiency is carcinogenic and can either have somatic/sporadic causes (i.e. e...
Corlorectal cancer affects 5% of individuals in the Western world and heredity is estimated to cause...
Introduction Microsatellite instability occurs due to a series of mutations in the DNA pairing erro...
Purpose. Microsatellite instability (MSI) caused by mismatch repair protein (MMRP) deficiency is det...
Abstract Background This study aimed to identify patients with upper urinary tract urothelial carcin...
Background: Immunohistochemical staining for mismatch repair proteins is efficient and widely used t...
Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. A...
Background: Patients with early-onset colorectal cancer (CRC) or those with multiple tumours associa...
Urothelial carcinoma of the renal pelvis and ureter may develop sporadically or as a manifestation o...
Urothelial carcinoma of the renal pelvis and ureter may develop sporadically or as a manifestation o...
Urothelial carcinoma of the renal pelvis and ureter may develop as a manifestation of the hereditary...
Inactivation of the DNA mismatch repair (MMR) system is a tumorigenic mechanism involved in 15-20% o...
To date, two forms of microsatellite instability (MSI) have been described in human cancer. MSI typi...
Introduction: Lynch syndrome-associated cancer develops due to germline pathogenic variants in one o...
BACKGROUND. Patients with the familial syndrome hereditary nonpolyposis colorectal carcinoma (HNPCC)...
Mismatch repair (MMR) deficiency is carcinogenic and can either have somatic/sporadic causes (i.e. e...
Corlorectal cancer affects 5% of individuals in the Western world and heredity is estimated to cause...
Introduction Microsatellite instability occurs due to a series of mutations in the DNA pairing erro...
Purpose. Microsatellite instability (MSI) caused by mismatch repair protein (MMRP) deficiency is det...
Abstract Background This study aimed to identify patients with upper urinary tract urothelial carcin...
Background: Immunohistochemical staining for mismatch repair proteins is efficient and widely used t...
Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. A...
Background: Patients with early-onset colorectal cancer (CRC) or those with multiple tumours associa...